NCRIS Joint Grant Award (Collaborative)

​

Objective

National Cancer Research Institute Singapore (NCRIS) is a Joint Research Institute that is formed between Duke-NUS Cancer and Stem Cell Biology (CSCB) Programme and National Cancer Centre Singapore (NCCS) under the purview of the SingHealth Duke-NUS Academic Medical Centre (SingHealth Duke-NUS AMC).

Cancer is an identified research focus area in both RIE2020 and AMC Masterplan, and the NCRIS Joint Grant Call seeks to provide greater collaborative opportunities within the SingHealth Duke-NUS AMC. The NCRIS Joint Grant Award (Collaborative) grant aims to strengthen the collaboration between two junior Principal Investigators (PIs) from SingHealth Institutes and Cancer & Stem Cell Biology Programme (CSCB) in Duke-NUS on cancer-relevant project. Priority is given to applications with clear synergies and bridging between CSCB and SingHealth Institutes.      

The NCRIS Joint Grant Award (Collaborative) grant encourages clinician-scientists to either collaborate amongst themselves or with their PhD-trained scientist counterparts, to generate translational or clinical research that has potential for bench-to-bedside or bedside-to-bench applications. The fund is intended to help the PIs develop a research project for publication and/or to prepare for a joint large competitive grant.

Funding Details

The grant award is up S$100,000 ($50,000 per PI/lab) over a period of 1 year which is to be shared between the two PIs.

Eligibility Criteria

Each proposal must involve a demonstrable research collaboration between the 2 Co-Principal Investigators (Co-PIs) – 1 Co-PI from SingHealth and 1 Co-PI from CSCB in Duke-NUS. 

Criteria for the applicants:

1. Applicant from Duke-NUS must hold a Primary Duke-NUS appointment (75% FTE or above) and have a PhD or equivalent qualification with at least 6 years of post-doctoral research experience in relevant local or overseas universities, research institutes, centres, etc., at time of application.

2. Applicant from SingHealth Institutes must hold a Primary SingHealth appointment (75% FTE or above), and either be clinically qualified (i.e. with MD/ MBBS/ BDS/ PharmD) or have a PhD qualification with at least 6 years of post-doctoral research experience in relevant local or overseas universities, research institutes, centres, etc., at time of application.

Submission

Each application involves 1 SingHealth Co-PI and 1 CSCB Co-PI in Duke-NUS. Between the 2 Co-PIs, 1 Co-PI should be appointed the designated primary point of contact who will be responsible for submitting the completed application form and all accompanying documents.

Applicants are to submit their completed applications (1 soft copy) using the attached application form 'Final_NCRIS_Joint_Grant_Call_Dec 2019' by 10 January 2020, 12 noon. 

• If the designated primary contact is CSCB Co-PI, please send the completed application to jamie.liew@duke-nus.edu.sg.
• If the designated primary contact is SingHealth Co-PI, please send the completed application to koh.liang.kai@nccs.com.sg.

Shortlisted applicants will be invited to give a presentation before a final selection panel.

Successful applicants will be expected to present their research findings at the CSCB/NCCS Joint Research-In-Progress seminar and/or annual retreat.

Note: SingHealth PIs are to please refer to your respective Institutional Research Administrators for guidance on internal deadlines and submission procedures set by your institutions.

Contact Person

1. Mr Koh Liang Kai

Tel no: 6325 1253

Email: koh.liang.kai@nccs.com.sg

2. Ms Jamie Liew 

Email: jamie.liew@duke-nus.edu.sg 

Additional Information

• Final_NCRIS_Joint_Grant_Call_Dec 2019